madman Super Moderator Apr 9, 2018 #1 [URL="https://www.urotoday.com/recent-abstracts/urologic-oncology/prostate-cancer/103374-shifting-the-paradigm-of-testosterone-replacement-therapy-in-prostate-cancer.html"][FONT="]Historically, testosterone and prostate cancer have been demonstrated to have a positive association leading providers to forgo testosterone replacement therapy (TRT) in men with concurrent histories of hypogonadism and prostate cancer. This paradigm has been gradually shifting with our evolving understanding of the relationship between testosterone and prostate cancer and the gaining popularity of the saturation model. Newer data suggests improved quality of life for men with hypogonadism after TRT leading to a more tempered view of the effects of this treatment and its risk in prostate cancer. As more reports emerge of TRT in men who have either undergone definitive treatment for prostate cancer or are on active surveillance, some providers see a role for TRT in these patients despite non-consensus in clinical guidelines. It is critical that we examine evidence currently available, while we await more rigorous data to emerge.[/FONT] Click to expand... [FONT="]The world journal of men's health. 2018 Mar 22 [Epub ahead of print][/FONT] [FONT="]Michael A Bell, Jeffrey D Campbell, Gregory Joice, Nikolai A Sopko, Arthur L Burnett[/FONT] Click to expand... https://www.urotoday.com/recent-abstracts/urologic-oncology/prostate-cancer/103374-shifting-the-paradigm-of-testosterone-replacement-therapy-in-prostate-cancer.html[/URL] Last edited by a moderator: Apr 10, 2018
[URL="https://www.urotoday.com/recent-abstracts/urologic-oncology/prostate-cancer/103374-shifting-the-paradigm-of-testosterone-replacement-therapy-in-prostate-cancer.html"][FONT="]Historically, testosterone and prostate cancer have been demonstrated to have a positive association leading providers to forgo testosterone replacement therapy (TRT) in men with concurrent histories of hypogonadism and prostate cancer. This paradigm has been gradually shifting with our evolving understanding of the relationship between testosterone and prostate cancer and the gaining popularity of the saturation model. Newer data suggests improved quality of life for men with hypogonadism after TRT leading to a more tempered view of the effects of this treatment and its risk in prostate cancer. As more reports emerge of TRT in men who have either undergone definitive treatment for prostate cancer or are on active surveillance, some providers see a role for TRT in these patients despite non-consensus in clinical guidelines. It is critical that we examine evidence currently available, while we await more rigorous data to emerge.[/FONT] Click to expand... [FONT="]The world journal of men's health. 2018 Mar 22 [Epub ahead of print][/FONT] [FONT="]Michael A Bell, Jeffrey D Campbell, Gregory Joice, Nikolai A Sopko, Arthur L Burnett[/FONT] Click to expand... https://www.urotoday.com/recent-abstracts/urologic-oncology/prostate-cancer/103374-shifting-the-paradigm-of-testosterone-replacement-therapy-in-prostate-cancer.html[/URL]
P Pauly_P Member Apr 10, 2018 #2 Thank you for posting Madman, I was able to get the entire text. Sweet!
D Deleted member 16042 Member Apr 10, 2018 #3 Related: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4814970/
Z ZoomyR6 Member Apr 12, 2018 #4 Off topic. Madman, been trying to reach back out to you. Clear that inbox.
madman Super Moderator Apr 12, 2018 #5 ZoomyR6 said: Off topic. Madman, been trying to reach back out to you. Clear that inbox. Click to expand... All good now!
ZoomyR6 said: Off topic. Madman, been trying to reach back out to you. Clear that inbox. Click to expand... All good now!
